Corvus Pharmaceuticals CRVS Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Corvus Pharmaceuticals's investing cash flow?
- Corvus Pharmaceuticals (CRVS) reported investing cash flow of -$144.85M in Q1 2026.
- How has Corvus Pharmaceuticals's investing cash flow changed year-over-year?
- Corvus Pharmaceuticals's investing cash flow decreased by 3513.8% year-over-year, from $4.24M to -$144.85M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.